Three days of remdesivir cuts risk for severe COVID-19 in outpatients
As omicron spreads, child hospitalizations climb 30% in past week
29 December 2021Healthy diet in early pregnancy reduces risk of gestational diabetes
29 December 2021Three days of remdesivir cuts risk for severe COVID-19 in outpatients
A three-day course of remdesivir results in a lower risk for hospitalization or death compered with placebo among nonhospitalized patients at high risk for COVID-19 progression, according to a study published online Dec. 22 in the New England Journal of Medicine.
